Guidelines for the management of adult lower respiratory tract infections--summary.

@article{Woodhead2011GuidelinesFT,
  title={Guidelines for the management of adult lower respiratory tract infections--summary.},
  author={Mark A. Woodhead and F. Blasi and Santiago Ewig and Javier Garau and G{\'e}rard Huchon and Margaretha M. Ieven and Ake Ortqvist and Tom Schaberg and Antoni Torres and Geert J van der Heijden and Robert C Read and Theo J Verheij},
  journal={Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases},
  year={2011},
  volume={17 Suppl 6},
  pages={
          1-24
        }
}
  • M. Woodhead, F. Blasi, T. Verheij
  • Published 1 November 2011
  • Medicine
  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
This document is an update of Guidelines published in 2005 and now includes scientific publications through to May 2010. It provides evidence-based recommendations for the most common management questions occurring in routine clinical practice in the management of adult patients with LRTI. Topics include management outside hospital, management inside hospital (including community-acquired pneumonia (CAP), acute exacerbations of COPD (AECOPD), acute exacerbations of bronchiectasis) and… 

The clinical management of lower respiratory tract infections

Antibiotics are the main choice of treatment for patients with pneumonia, acute exacerbations of COPD (including increased sputum purulence and worsening shortness of breath) and AE of non-CF bronchiectasis and inhaled antibiotics may represent a more optimal approach for the treatment and prevention of AE ofnon- CF bronchiectomy.

Management of lower respiratory tract infection in outpatient settings: Focus on clarithromycin

  • A. Mahashur
  • Medicine, Biology
    Lung India : official organ of Indian Chest Society
  • 2018
The management approach of LRTI with focus on clarithromycin in the management of mild-to-moderate LRTIs (CAP and AECB), i.e., in outpatient settings is discussed.

Appropriate antibiotic management of bacterial lower respiratory tract infections

Lower respiratory tract infections are the leading cause of infectious disease deaths worldwide and are the fifth leading cause of death overall. This is despite conditions such as pneumococcal

Using Standardized Care Bundles in the Emergency Department to Decrease Mortality in Patients Presenting with Community-Acquired Pneumonia (CAP) and Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

The importance of clinical care bundles when managing community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease in the emergency department and its potential to decrease mortality are reviewed.

2018 recommendations for the management of community acquired pneumonia

  • R. A. CorrêaA. Costa M. Pereira
  • Medicine
    Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
  • 2018
Thirteen members with recognized experience in CAP in Brazil who identified issues relevant to clinical practice that require updates given the publication of new epidemiological and scientific evidence are summoned.

Federal guidelines on diagnosis and treatment of community-acquired pneumonia

The presented clinical guidelines cover current information about the etiology, clinical manifestations, diagnosis and treatment tactics for community-acquired pneumonia and have been approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation in 2021.

Treatment options for community-acquired pneumonia in the elderly people

The aim of this review is to give an update of the current antibiotic options for CAP in the elderly people reporting available data on the CAP etiology and risk factors, and tolerability, toxicity and pharmacokinetics/pharmacodynamic of antimicrobial agents used for elderly patients.

Federal guidelines on diagnosis and treatment of chronic bronchitis

The presented clinical guidelines for the diagnosis and treatment of chronic bronchitis were approved by the Scientific and Practical Council of the Ministry of Health of the Russian Federation in 2021 and contain comments and explanations to these theses.

Pharmacotherapy for lower respiratory tract infections

In an effort to manage chronic airway infection non-CF bronchiectasis due to drug-resistant pathogens, aerosolized antibiotics may be of value, and the data from recent studies are examined to demonstrate the potential value of this therapy.

An update on the pharmacotherapeutic management of lower respiratory tract infections

Biomarkers, mainly C-reactive protein (CRP) and procalcitonin (PCT), can improve the diagnostic and prognostic assessment of LRTIs and aid to guide antibiotic therapy.
...

References

SHOWING 1-10 OF 827 REFERENCES

Guidelines for management of adult community-acquired lower respiratory tract infections

The main goal of initial clinical evaluation is to determine whether the patient can be managed at home or whether there is evidence that suggests potential or immediate severity, or that the illness will follow a complicated course.

Guidelines for the management of adult lower respiratory tract infections

The guidelines cover the breadth of adult community-acquired respiratory infection, including prevention (both vaccine- and nonvaccine-related), infections in the community and infections in those admitted to hospital, including pneumonia, exacerbations of chronic obstructive pulmonary disease (COPD) and exacerbation of bronchiectasis.

Early switch to oral antibiotics and early discharge guidelines in the management of community‐acquired pneumonia

Assessment of guidelines on early switch to oral antibiotics and early discharge from hospital may help to achieve a unified approach to managing CAP in an Australian respiratory medicine unit.

Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published Evidence

The primary aims of this paper are 1) to summarize and evaluate published data that address care of patients with acute exacerbations of chronic obstructive pulmonary disease [COPD] and 2) to improve

Impact of Atypical Coverage for Patients with Community‐Acquired Pneumonia Managed on the Medical Ward: Results from the United States Community‐Acquired Pneumonia Project

Study Objective. As current guidelines for treatment of community‐acquired pneumonia (CAP) recommend empiric antimicrobial coverage for atypical pathogens, we evaluated the need for atypical coverage

Acute exacerbations of chronic bronchitis: an international comparison.

Therapy for patients with less severe AECB include older and less expensive broad-spectrum antibiotics, while newer agents are indicated for Patients with the most severe stage of A ECB.

Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule.

Linking antibiotic administration within 4 h of hospital admission (as a quality indicator) to financial compensation may result in an inaccurate diagnosis of CAP, inappropriate utilization of antibiotics, and thus less than optimal care.

Cost-effective therapy for acute exacerbations of chronic bronchitis.

The corollary is that aggressive therapy directed toward patients with either acute bronchitis or exacerbations of trivial chronic obstructive lung disease leads to emergence of resistance and increased costs.

Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: A 2‐year prospective study

To assess the risk factors associated with exacerbations and to compare these findings with published studies, the predominant bacterial pathogens cultured from sputum in community‐based patients with AECOPD were determined.

Adherence to guidelines’ empirical antibiotic recommendations and community-acquired pneumonia outcome

Adherence to the 2001 American Thoracic Society guidelines was high except in community-acquired pneumonia patients admitted to an intensive care unit, and length of stay was shorter in patients who received adherent rather than nonadherent antibiotic regimens.
...